Addition of Vitamin D Status to Prognostic Scores Improves the Prediction of Outcome in Community-Acquired PneumoniaHilde H.F. Remmelts, Ger T. Rijkers, E.M.W. van de Garde et al.|Clinical Infectious Diseases|2012Cited by 74
Dexamethasone Downregulates the Systemic Cytokine Response in Patients with Community-Acquired PneumoniaHilde H.F. Remmelts, Ger T. Rijkers, Sabine C A Meijvis et al.|Clinical and Vaccine Immunology|2012Cited by 62
Biomarkers define the clinical response to dexamethasone in community-acquired pneumoniaHilde H.F. Remmelts, Douwe H. Biesma, Sabine C A Meijvis et al.|Journal of Infection|2012Cited by 34
The role of vitamin D supplementation in the risk of developing pneumonia: three independent case–control studiesHilde H.F. Remmelts, E.M.W. van de Garde, Simone M.C. Spoorenberg et al.|Thorax|2013Cited by 28
ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trialEbru Dirikgil, Y K Onno Teng, Jolijn R. van Leeuwen et al.|BMJ Open|2022Cited by 16